PNEUMONIA is the #9 most commonly reported adverse reaction for FILGRASTIM, manufactured by Amgen, Inc. There are 1,865 FDA adverse event reports linking FILGRASTIM to PNEUMONIA. This represents approximately 2.4% of all 76,865 adverse event reports for this drug.
Patients taking FILGRASTIM who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PNEUMONIA1,865 of 76,865 reports
PNEUMONIA is a less commonly reported adverse event for FILGRASTIM, but still significant enough to appear in the safety profile.
Other Side Effects of FILGRASTIM
In addition to pneumonia, the following adverse reactions have been reported for FILGRASTIM:
PNEUMONIA has been reported as an adverse event in 1,865 FDA reports for FILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PNEUMONIA with FILGRASTIM?
PNEUMONIA accounts for approximately 2.4% of all adverse event reports for FILGRASTIM, making it a notable side effect.
What should I do if I experience PNEUMONIA while taking FILGRASTIM?
If you experience pneumonia while taking FILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.